Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEC22 homolog B3, pseudogene (SEC22B3P) is a processed pseudogene found on human chromosome 22[3][1]. It is highly similar in sequence to the functional SEC22 gene family, but mutations render it incapable of producing a functional SEC22B3 protein. As a pseudogene, SEC22B3P is not known to have a direct protein function or to act as a drug target, receptor, or enzyme. While some pseudogenes have regulatory roles through expression of noncoding RNAs, there is no published evidence for such functions in SEC22B3P specifically. SEC22B3P does not have known clinical significance, direct therapeutic potential, or established roles in disease, and is not associated with any pharmacological interventions[3][1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SEC22 homolog B3, pseudogene (SEC22B3P).